Trial Profile
Randomized, Parallel Group, Double-blind Trial to Evaluate Different Dose Combinations of Lercanidipine and Enalapril in Comparison With Each Component Administered Alone and With Placebo in Patients With Essential Hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2020
Price :
$35
*
At a glance
- Drugs Enalapril (Primary) ; Lercanidipine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms FELT
- Sponsors Recordati
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
- 21 Apr 2012 Additional locations (Germany, Poland, Spain) added as reported by European Clinical Trials Database record.
- 28 Apr 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.